MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03831cam a2200517 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
200454473 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
TR-AnTOB |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20230926152807.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS |
|---|
| fixed length control field |
m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
|---|
| fixed length control field |
cr cnu---unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
230820t20212021nju ob 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781119432487 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
1119432480 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
9781119432494 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
1119432499 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
9781119432456 |
| Qualifying information |
(e-book) |
|
|---|
| International Standard Book Number |
1119432456 |
| Qualifying information |
(e-book) |
|
|---|
| Canceled/invalid ISBN |
9781119432449 |
| Qualifying information |
hardcover |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1145092231 |
|
|---|
| System control number |
(TR-AnTOB)200454473 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
OCLCO |
| -- |
OCLCA |
| -- |
OCLCQ |
| -- |
DG1 |
| -- |
OCLCF |
| -- |
YDX |
| -- |
TR-AnTOB |
| 041 0# - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
İngilizce |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
QZ 269 |
| Item number |
P923 2021 |
| 096 ## - LOCALLY ASSIGNED NLM-TYPE CALL NUMBER (OCLC) |
|---|
| Classification number |
QZ269 |
| Item number |
P923 2021EBK |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Precision medicine in oncology / |
| Statement of responsibility, etc. |
edited by James A. Radosevich, Bulent Aydogan. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Hoboken, NJ : |
| Name of producer, publisher, distributor, manufacturer |
Wiley-Blackwell, |
| Date of production, publication, distribution, manufacture, or copyright notice |
2021. |
|
|---|
| Date of production, publication, distribution, manufacture, or copyright notice |
©2021 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xxii, 249 pages) |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
computer |
| Media type code |
c |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
online resource |
| Carrier type code |
cr |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Genomic Strategies for Personalized Cancer Therapy -- Blood-based biomarkers for the diagnosis and prognosis of cancer -- Application of circulating cell free DNA for personalized cancer therapy -- Prognostic Implications of EGFR, p53, p16, cyclin D1, Bcl-2 in Head & Neck Squamous Cell Carcinoma (HNSCC) -- Predictive and prognostic markers for cancer medicine -- Dual Energy Imaging in Precision Radiation Therapy -- The role of Big Data in personalized medicine |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"Most medical treatments have been designed for the "average patient." As a result of this "one-size-fits-all-approach," treatments can be very successful for some patients but not for others. This is changing with the emergence of precision medicine, an innovative approach to disease prevention and treatment that takes into account individual differences in people's genes, environments, and lifestyles. Precision medicine gives clinicians tools to better understand the complex mechanisms underlying a patient's health, disease, or condition, and to better predict which treatments will be most effective. Precision or personalized medicine in cancer treatment was once a buzzword, but it is finally becoming a reality with recent advances in imaging, genetic, and biological sciences. The importance of interpatient and intratumor variability has long been recognized, but realistic opportunities to take these into account in cancer care have emerged only recently. Innovations in patient characterization through genomics, proteomics, and metabolomics have opened new avenues to personalize cancer treatment in ways that were not possible before. Furthermore, advances in quantitative assessment of therapeutic response, as provided by functional and molecular imaging, have been critical in the implementation of precision medicine paradigm in radiation oncology. This book will be a comprehensive review of science and technology making precision medicine possible for radiation oncology, current examples and future direction"-- |
| Assigning source |
Provided by publisher |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Cancer |
| General subdivision |
Radiotherapy |
|
|---|
| Topical term or geographic name entry element |
Neoplasms |
| General subdivision |
radiotherapy |
| 9 (RLIN) |
143654 |
|
|---|
| Topical term or geographic name entry element |
Precision Medicine |
| General subdivision |
methods |
| 9 (RLIN) |
143655 |
| 655 #0 - INDEX TERM--GENRE/FORM |
|---|
| Genre/form data or focus term |
Electronic books |
| 9 (RLIN) |
2032 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Radosevich, James A. |
| Fuller form of name |
(James Andrew) |
| Relator term |
editor |
| 9 (RLIN) |
143656 |
|
|---|
| Personal name |
Aydoğan, Bülent |
| Relator term |
editor |
| 9 (RLIN) |
143657 |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
|---|
| Relationship information |
Print version: |
| Title |
Precision medicine in oncology |
| Place, publisher, and date of publication |
Hoboken, NJ : Wiley-Blackwell, 2021. |
| International Standard Book Number |
9781119432449 |
| Record control number |
(DLC) 2020012104 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Wiley Online Library |
| Public note |
Online access link to the resource |
| Uniform Resource Identifier |
<a href="https://onlinelibrary.wiley.com/doi/book/10.1002/9781119432487">https://onlinelibrary.wiley.com/doi/book/10.1002/9781119432487</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
National Library of Medicine |
| Koha item type |
E-Book |
